The EpiQuik™ HAT Activity/Inhibition Assay Kit is a ready-to-use set of essential components needed to measure histone acetyltransferase activity/inhibition safely and quickly. It is suitable for measuring histone acetyltransferase activity/inhibition from a broad range of species including mammalian cells/tissues, plants, and bacteria.

WHY CHOOSE THE EPIQUIK™ HAT ACTIVITY/INHIBITION ASSAY KIT (COLORIMETRIC)?

• Very quick procedure, which can be completed within only 3 hours.
• Innovative colorimetric assay without radioactivity, extraction, and chromatography.
• Direct measurement of HAT activity and inhibition by quantifying the amount of acetylated histone substrate, thereby avoiding the false inhibitory effect on HATs.
• Strip microplate format makes the assay flexible in both manual and high throughput analysis formats.
• Simple, reliable, and consistent assay conditions.

The EpiQuik™ HAT Activity/Inhibition Assay Kit is designed for measuring total histone aceyltransferase activity or inhibition. In an assay with this kit, the unique histone substrate is stably captured on the strip wells. Active HATs bind to and acetylate histone substrate. The acetylated substrate can be recognized with a high affinity anti-acetylated histone antibody. The ratio or amount of the acetylated histone, which is directly proportional to HAT enzyme activity, can then be colorimetrically quantified through an ELISA-like reaction.

SCHEMATIC PROCEDURE:

HT1 (10X Wash Buffer)
HT2 (HAT Substrate, 20 µg/ml)*
HT3 (HAT Standard, 20 µg/ml)*
HT4 (Acetyl Co-A, 30 mM)*
HT5 (HAT Assay Buffer)
HT6 (Capture Antibody, 100 µg/ml)*
HT7 (Detection Antibody, 200 µg/ml)*
HT8 (Developing Solution)
HT9 (Stop Solution)
8-Well Assay Strip (with Frame)
User Guide

*For maximum recovery of the products, centrifuge the original vial after thawing prior to opening the cap.

[User Guide]* *Always use the actual User Guide that shipped with your product. Is the above file locked? You can also request user guides by emailing info@epigentek.com along with your contact information and institution name.

Nishino, T. et. al. (September 2011). Ex vivo expansion of human hematopoietic stem cells by garcinol, a potent inhibitor of histone acetyltransferase. PLoS One. 6(9):e24298. PubMed Abstract

Kraft, M. et. al. (September 2011). Disruption of the histone acetyltransferase MYST4 leads to a Noonan syndrome–like phenotype and hyperactivated MAPK signaling in humans and mice. J Clin Invest. 121(9):3479-3491. PubMed Abstract

Czakai, K. et. al. (May 2011). Perturbation of mitosis through inhibition of histone acetyltransferases: the key to ochratoxin A toxicity and carcinogenicity? Toxicol Sci. Epub ahead of print. PubMed Abstract

Meeran, S. M. et. al. (March 2011). A Novel Prodrug of Epigallocatechin-3-gallate: Differential Epigenetic hTERT Repression in Human Breast Cancer Cells. Cancer Prev Res (Phila). Epub ahead of print. PubMed Abstract

Pascual, M. et. al. (February 2011). Impact of TLR4 on behavioral and cognitive dysfunctions associated with alcohol-induced neuroinflammatory damage. Brain Behav Immun. Epub ahead of print. PubMed Abstract 

Li, Y. et. al. (October 2010). Synergistic epigenetic reactivation of estrogen receptor-α (ERα) by combined green tea polyphenol and histone deacetylase inhibitor in ERα-negative breast cancer cells. Molecular Cancer. 9: 274. PubMed Abstract

Meeran, S. M. et. al. (July 2010). Sulforaphane Causes Epigenetic Repression of hTERT Expression in Human Breast Cancer Cell Lines. PLoS One. 5(7): e11457. PubMed Abstract

Majid, S. et. al. (January 2010). Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer. Cancer. 116(1): 66-76. PubMed Abstract

Watson, J. A. et. al. (October 2009). Generation of an epigenetic signature by chronic hypoxia in prostate cells. Human Molecular Genetics. 18(19): 3594-604. PubMed Abstract

Majid, S. et. al. (April 2009). BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis. 30(4):662-670. PubMed Abstract

Majid, S. et. al. (February 2009). BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis Advance Access. 30(4): 662-670. PubMed Abstract